Professional Documents
Culture Documents
3. Text Book:
TB1: Michael B. Smith & Jerry March, Advanced Organic Chemistry, John Wiley & Sons,
6th ed., 2012.
TB2: Stuart Warren: Organic Synthesis: The Disconnection Approach: John Wiley &
Sons, 2004.
Reference Books:
R1: Carruthers and Coldham, Modern Methods of Organic Synthesis, Cambridge, 4 th
edition, 2004.
R2: Fuhrhop and Li, Organic Synthesis: Concepts and Methods; Wiley, 3rd edition, 2014.
4. Course Plan:
Lec. No. Learning Objectives Topic(s) to be Covered Chap(s). No(s).
2-5 Common organic NaBH4 (SS), LAH (SS), DIBAL, BH3, Birch TB1: 15-13;
reagents reduction, Swern oxidation, OsO4, O3 Class notes, SS:
(SS), DMP, m-CPBA (SS), Ti(iOPr)4, self-study
Lindlar catalyst, NBS (SS), NaIO4 (SS)
32-38 Ring synthesis Introduction to Ring synthesis, TB2: 29, 30, 34,
(saturated Synthesis of three, four, five and six 36, 37
heterocycles) membered Rings and general strategy of
Ring Synthesis
39-40 Synthesis of Aromatic Heterocycles TB2: 39
heterocyclic
compounds
5. Evaluation Scheme
Component Duration Weightage (%) Date and Time Remarks
Midsem. Test 90 min 30 22/10/2021 3.30 - 5.00PM Closed Book
20 % Closed book
Comprehensive Partially
120 min + 24/12 FN
Examination Open Book
20 % Open book
*Six class tests will be conducted at regular intervals. Best four will be considered.
Make Up is not permissible for class tests.
One home assignment would be given and each student is expected to submit (last
#
Note: Active and regular participation in class discussions is expected from each student.
6. Chamber Consultation Hour: Thursday, 11.00-12.00 noon
What is Organic Chemistry?
Largest area of specialization among the various fields of chemistry
Synthetic Organic Chemistry
· Pharmaceutical Chemistry
· Polymer Chemistry
· Dye and Textile Chemistry
· Pulp and Paper Chemistry
· Agricultural Chemistry
· Formulation Chemistry (paint, food, petroleum products, adhesives, etc.)
Synthesis is championship of
human being against nature.
Method
R.B. Woodward (1917-1979)
quinine
cholesterol cortisone
R.B. Woodward (Early Career 1940’s…)
R.B. Woodward (Later Career…)
Vitamin B12
1972
K.C. Nicolaou
Penn (1977-1989)
Scripps Research Institute and
UC-San Diego (1989-2012)
Currently at Rice University since
2013
Modern day R.B. Woodward
He is the author or co-author of more than 790 scientific articles, reviews, and book
chapters, 79 patents, and five books.
40 hydroxy groups
64 chiral centers
1021 stereoisomers
Why do people synthesize organic molecules?
Prove structure of a natural product
Prove it can be synthesized in laboratory
Gain insights to reactivity based on structure 1930-1975
Test synthetic methodology
Physical organic chemical studies
Synthesis these days is done for all of the above reasons & to
Construct nanostructure
Apply or test a biological utility or theory
Gain enough synthetic knowledge of the molecular architecture of
natural product to be able to make analogues for drug testing.
For organic synthesis
The targets can be natural products……….
Swinholide A
Antibiotic of last resort against Cytotoxic potent activity against
drug resistant bacteria MDR resistant carcinoma cell lines
J. Am. Chem. Soc.1999, 121, 10004-10011
J. Am. Chem. Soc. 2016, 138, 14246−14249
The targets can be compounds with interesting activities……….
Parathion
insecticide
Fluoxetine, Prozac
Aspirin anti-depressant
Indinavir, Crivixan
anti-HIV
Allura red
red pigment
Bedaquiline, Sirturo
anti-TB
Doxorubicin, Adriamycin
anti-cancer
The targets can be compounds with interesting activities……….
Remdesivir
Anti-viral
DOI: 10.1056/NEJMoa2007764
NEJM - 22 May 2020
For every 25,000 compounds that start in the laboratory, 25 are tested in
humans, 5 make it to market and just one recoups what was invested.
Phase I trials, usually in healthy volunteers, determine safety and dosing.
Phase II trials are used to get an initial reading of efficacy and further
explore safety in small numbers of sick patients.
Phase III trials are large, pivotal trials to determine safety and efficacy in
sufficiently large numbers of patients.
Costs for one drug molecule vary from around $500 million to $2
billion depending on the therapy or the developing firm.
The targets can be compounds with artistic & anthromorphic
attributes………….